Drug Profile
Research programme: epitope-based vaccines - EpiVax
Alternative Names: Biodefense vaccines - EpiVaxLatest Information Update: 23 Feb 2023
Price :
$50
*
At a glance
- Originator EpiVax
- Class Bacterial vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Encephalitis virus infections; Smallpox; Tularaemia
- Discontinued Helicobacter infections; Influenza A virus H1N1 subtype; Tuberculosis
Most Recent Events
- 23 Feb 2023 Discontinued - Preclinical for Helicobacter infections (Prevention) in USA (Parenteral)
- 23 Feb 2023 Discontinued - Preclinical for Influenza A virus H1N1 subtype (Prevention) in USA (Parenteral)
- 23 Feb 2023 Discontinued - Preclinical for Tuberculosis (Prevention) in USA (Parenteral)